Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clerkenwell Health has established itself as a leading CRO specializing in the design and delivery of clinical trials for psychiatric, CNS, and psychedelic therapies. It operates Europe’s first commercial research site dedicated to psychedelic trials, supporting studies from preclinical through Phase III. The company has enabled accelerated patient access and innovative trial designs but does not publish its own clinical results as it acts as a service provider rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clerkenwell Health.